35 - GenAI's Legal Challenge | Investors Questioning VC Valuations | Lilly Going Direct to Consumers | Elevance Adds Large Infusion Service

Show Notes

Welcome to the first episode of 2024! In this episode, we are addressing the following topics and more:

• GenAI's Legal Challenge
• Investors Questioning VC Valuations
• Lilly Going Direct to Consumers
• Elevance Adds Large Infusion Service
• Secret to Longevity & Happiness

Please check out our Episode Resources below:

------🔎RESOURCES🔎

Things are about to get a lot worse for Generative AI (Substack: Marcus on AI) // https://bit.ly/47onyV6

Goldman Sachs Raises $650 Million for Life-Sciences Bets (WSJ) // https://on.wsj.com/3TW6q65

LPs Doubt Venture Funds’ Startup Valuations (WSJ) // https://bit.ly/41O9O4C

Japanese Investors Return to Overseas Real Estate With Lessons From the 1990s (WSJ) // https://on.wsj.com/3H74lfZ

A fix for the coming physician shortage (FreeOpp) // https://bit.ly/3vkFhiG

Elevance Health to Acquire Paragon Healthcare (Press Release) // https://bit.ly/48ImFaL

Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect™ (Press Release) // https://prn.to/3RN6dze

How to Work—and Love It—Into Your 80s and Beyond (WSJ) // https://on.wsj.com/48mDOa9

------🔔SIGN UP FOR EPISODE NOTIFICATIONS🔔

https://www.podpage.com/healthfurther/

------📱FOLLOW HEALTH:FURTHER SOCIA

HF Site

YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK

What is Health:Further?

Every week, healthcare VCs and Jumpstart Health Investors co-founders Vic Gatto and Marcus Whitney review and unpack the happenings in US Healthcare, finance, technology and policy. With a firm belief that our healthcare system is doomed without entrepreneurship, they work through the mud to find the jewels, highlight headwinds and tailwinds, and bring on the smartest guests to fill in the gaps.